Appendix to the Note for Guidance on the Clinical investigation of medicinal products in the treatment of schizophrenia (CPMP/ EWP/ 559/ 95) – methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia.
Revision of Note for Guidance on evaluation of new anti- bacterial medicinal products (CPMP/EWP/558/95) and Note for